Article
A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.
Development (Cambridge, England) - 1 Aug 2010
Pei Wuhong, Kratz Lisa E, Bernardini Isa, Sood Raman, Yokogawa Tohei, Dorward Heidi, Ciccone Carla, Kelley Richard I, Anikster Yair, Burgess Harold A, Huizing Marjan, Feldman Benjamin
Abstract excerpt
Costeff Syndrome, which is caused by mutations in the OPTIC ATROPHY 3 (OPA3) gene, is an early-onset syndrome characterized by urinary excretion of 3-methylglutaconic acid (MGC), optic atrophy and movement disorders, including ataxia and extrapyramidal dysfunction. The OPA3 protein is enriched in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
